Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion type Assertion NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_head.
- NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion description "[Subsets with 'CLL-biased' homologous complementarity-determining region 3 (CDR3) were identified: (1) IGKV2-30-IGKJ2, 7 sequences with homologous kappa CDR3 (KCDR3), 5 of 7 associated with homologous IGHV4-34 heavy chains; (2) IGKV1-39/1D-39-IGKJ1/4, 4 unmutated sequences with homologous KCDR3, 2 of 4 associated with homologous IGHV4-39 heavy chains; (3) IGKV1-5-IGKJ1/3, 4 sequences with homologous KCDR3, 2 of 4 associated with unmutated nonhomologous IGHV4-39 heavy chains; (4) IGLV1-44-IGLJ2/3, 2 sequences with homologous lambda CDR3 (LCDR3), associated with homologous IGHV4-b heavy chains; and (5) IGLV3-21-IGLJ2/3, 9 sequences with homologous LCDR3, 3 of 9 associated with homologous IGHV3-21 heavy chains.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_provenance.
- NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion evidence source_evidence_literature NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_provenance.
- NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion SIO_000772 16076869 NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_provenance.
- NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion wasDerivedFrom befree-20150227 NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_provenance.
- NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_assertion wasGeneratedBy ECO_0000203 NP891712.RAxC-h-02AP_AYtanhey7I2ewfOogRDrEswqf4jxSgWfQ130_provenance.